Apollo Neuroscience, Inc. — Form D/A

Apollo Neuroscience, Inc. of PITTSBURGH, PA, a company, filed a Form D amendment with the SEC on 2021-02-12. The offering totals $5.9M, of which $5.9M was reported sold. Industry: Other Health Care.

Offering

Filed: 2021-02-12
Form: D/A
Accession: 0001735427-21-000001
Industry: Other Health Care
Exemptions: 06b
Total offering: $5.9M
Amount sold: $5.9M
Investors: 51
Date of first sale: 2018-06-18
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-316049

Issuer

Name: Apollo Neuroscience, Inc.
CIK: 0001735427
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 1942 FIFTH AVENUE, PITTSBURGH, PA, 15219
Phone: (518) 312-0567

Officers, directors & promoters (9)

Name	Role	Location
Gary Johnson	Director	Waltham, MA
Alan Cannistraro	Director	Pittsburgh, PA
Alan Cannistraro	Executive Officer	Pittsburgh, PA
Kathryn Fantauzzi	Director	Pittsburgh, PA
Kathryn Fantauzzi	Executive Officer	Pittsburgh, PA
Kathryn Fantauzzi	Promoter	Pittsburgh, PA
David Rabin	Director	Pittsburgh, PA
David Rabin	Executive Officer	Pittsburgh, PA
Sa'ad Shah	Director	Pittsburgh, PA

Other filings by this issuer (9)

Filed	Form	Offering	Sold
2024-04-30	D	$2.0M	$500K
2024-04-29	D/A	$15.0M	$9.3M
2023-10-12	D/A	$10.0M	$6.0M
2023-02-22	D	$5.0M	$1.1M
2021-09-30	D/A	$15.0M	$8.0M
2021-05-25	D	$7.0M	$4.1M
2020-05-07	D/A	$5.0M	$4.1M
2018-07-03	D	$4.0M	$1.5M
2018-03-28	D	$250K	$100K

More